Debt-to-equity of AVENUE THERAPEUTICS, INC. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AVENUE THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • AVENUE THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 35%, a 14% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AVENUE THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 35% -5.5% -14% 30 Sep 2025
Q2 2025 34% -125% -79% 30 Jun 2025
Q1 2025 31% +369% 31 Mar 2025
Q4 2024 34% +312% 31 Dec 2024
Q3 2024 40% +454% 30 Sep 2024
Q2 2024 159% +933% 30 Jun 2024
Q1 2024 -338% -843% -167% 31 Mar 2024
Q4 2023 -278% -374% -390% 31 Dec 2023
Q3 2023 -414% -459% -1019% 30 Sep 2023
Q2 2023 -774% -824% -1625% 30 Jun 2023
Q1 2023 505% +452% +851% 31 Mar 2023
Q4 2022 96% +52% +119% 31 Dec 2022
Q3 2022 45% -19% -29% 30 Sep 2022
Q2 2022 51% +12% +29% 30 Jun 2022
Q1 2022 53% +20% +60% 31 Mar 2022
Q4 2021 44% +17% +63% 31 Dec 2021
Q3 2021 64% +37% +136% 30 Sep 2021
Q2 2021 39% +18% +81% 30 Jun 2021
Q1 2021 33% +16% +89% 31 Mar 2021
Q4 2020 27% -1.8% -6.4% 31 Dec 2020
Q3 2020 27% -13% -32% 30 Sep 2020
Q2 2020 22% -30% -58% 30 Jun 2020
Q1 2020 18% -60% -78% 31 Mar 2020
Q4 2019 29% -80% -74% 31 Dec 2019
Q3 2019 40% -2.6% -6.2% 30 Sep 2019
Q2 2019 52% +26% +98% 30 Jun 2019
Q1 2019 78% +55% +242% 31 Mar 2019
Q4 2018 109% +74% +213% 31 Dec 2018
Q3 2018 43% -37% -46% 30 Sep 2018
Q2 2018 26% 30 Jun 2018
Q1 2018 23% 31 Mar 2018
Q4 2017 35% 31 Dec 2017
Q3 2017 79% 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.